Evolus EOLS
NASDAQ EOLS
$8.35 -0.25 (-2.91%)
At close: Aug 20, 2026 · 4:00 PM EDT

Evolus (EOLS) Return on Invested Capital Growth (1y) (2019 - 2025)

Evolus (EOLS) Return on Invested Capital Growth (1y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (1y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 0.00
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 0.00
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 1.00
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 3.00
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Evolus 552.49 Mn 507.32 Mn 57.18 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 1.00
Sep 30, 2021 -1.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00